YTEN | Yield10 Bioscience, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.5000 - 0.5000
52 Week Range	0.3500 - 17.28
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	400
Average Volume	3,681
Shares Outstanding	692,683
Market Cap	346,342
Sector	Basic Materials
Industry	Agricultural Inputs
IPO Date	2006-11-10

Valuation
Profitability
Growth
Health
P/E Ratio	-0.02
Forward P/E Ratio	N/A
EPS	-20.14
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	29
Country	USA
Website	YTEN

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.

YTEN's peers: CGA

*Chart delayed

Analyzing fundamentals for YTEN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see YTEN Fundamentals page.

Watching at YTEN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on YTEN Technicals page.